ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells
- PMID: 24339741
- PMCID: PMC3858895
- DOI: 10.1593/neo.131310
ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells
Abstract
The t(12;21)(p13;q22) chromosomal translocation is the most frequent translocation in childhood B cell precursor-acute lymphoblastic leukemia and results in the expression of an ETV6/RUNX1 fusion protein. The frequency of ETV6/RUNX1 fusions in newborns clearly exceeds the leukemia rate revealing that additional events occur in ETV6/RUNX1-positive cells for leukemic transformation. Hitherto, the mechanisms triggering these second hits remain largely elusive. Thus, we generated a novel ETV6/RUNX1 transgenic mouse model where the expression of the fusion protein is restricted to CD19(+) B cells. These animals harbor regular B cell development and lack gross abnormalities. We established stable pro-B cell lines carrying the ETV6/RUNX1 transgene that allowed us to investigate whether ETV6/RUNX1 itself favors the acquisition of second hits. Remarkably, these pro-B cell lines as well as primary bone marrow cells derived from ETV6/RUNX1 transgenic animals display elevated levels of reactive oxygen species (ROS) as tested with ETV6/RUNX1 transgenic dihydroethidium staining. In line, intracellular phospho-histone H2AX flow cytometry and comet assay revealed increased DNA damage indicating that ETV6/RUNX1 expression enhances ROS. On the basis of our data, we propose the following model: the expression of ETV6/RUNX1 creates a preleukemic clone and leads to increased ROS levels. These elevated ROS favor the accumulation of secondary hits by increasing genetic instability and double-strand breaks, thus allowing preleukemic clones to develop into fully transformed leukemic cells.
Figures




Similar articles
-
ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.Blood Cells Mol Dis. 2016 Mar;57:30-4. doi: 10.1016/j.bcmd.2015.11.006. Epub 2015 Nov 15. Blood Cells Mol Dis. 2016. PMID: 26852652
-
RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.Cancer Med. 2021 Jun;10(12):3997-4003. doi: 10.1002/cam4.3928. Epub 2021 May 13. Cancer Med. 2021. PMID: 33987955 Free PMC article.
-
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche.Br J Haematol. 2020 Jul;190(2):262-273. doi: 10.1111/bjh.16523. Epub 2020 Mar 2. Br J Haematol. 2020. PMID: 32118299
-
The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21).Cells. 2023 Jan 18;12(3):357. doi: 10.3390/cells12030357. Cells. 2023. PMID: 36766699 Free PMC article. Review.
-
Siblings with ETV6/RUNX1-positive B-lymphoblastic leukemia: A single site experience and review of the literature.Ann Diagn Pathol. 2020 Oct;48:151588. doi: 10.1016/j.anndiagpath.2020.151588. Epub 2020 Aug 14. Ann Diagn Pathol. 2020. PMID: 32836179 Review.
Cited by
-
Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses.Antioxidants (Basel). 2021 Oct 14;10(10):1616. doi: 10.3390/antiox10101616. Antioxidants (Basel). 2021. PMID: 34679751 Free PMC article. Review.
-
Oxidative stress is two-sided in the treatment of acute myeloid leukemia.Cancer Med. 2024 May;13(9):e6806. doi: 10.1002/cam4.6806. Cancer Med. 2024. PMID: 38715546 Free PMC article. Review.
-
New insights into redox homeostasis as a therapeutic target in B-cell malignancies.Curr Opin Hematol. 2017 Jul;24(4):393-401. doi: 10.1097/MOH.0000000000000351. Curr Opin Hematol. 2017. PMID: 28402987 Free PMC article. Review.
-
Quantitative analysis of redox proteome reveals oxidation-sensitive protein thiols acting in fundamental processes of developmental hematopoiesis.Redox Biol. 2022 Jul;53:102343. doi: 10.1016/j.redox.2022.102343. Epub 2022 May 23. Redox Biol. 2022. PMID: 35640380 Free PMC article.
-
The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia.Front Cell Dev Biol. 2021 Jul 15;9:704591. doi: 10.3389/fcell.2021.704591. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34336858 Free PMC article.
References
-
- Fears S, Vignon C, Bohlander SK, Smith S, Rowley JD, Nucifora G. Correlation between the ETV6/CBFA2 (TEL/AML1) fusion gene and karyotypic abnormalities in children with B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer. 1996;17:127–135. - PubMed
-
- Romana SP, Mauchauffé M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood. 1995;85:3662–3670. - PubMed
-
- Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood. 2003;102:2321–2333. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases